Scholarship table
Hm.. I don't doubt the storyis true, but it is possible his first positive test result was a false positive (mild cough, sore throat) and he's actually got covid-19 now.
But the article says that her doctors don’t believe it’s a new infection. They believe that the virus went dormant and then re-emerged. Which is also not a good scenario.
If antibodies don’t confer immunity then the search for a vaccine is a fruitless effort and would also undermine most of what we know about virology in general. It’s highly doubtful there isn’t more to the story here.
Gooo has touched on this before, but there is a very specific type of antibody that is believed to generate some degree/form of immunity. The Mayo Clinic is working on a test for those antibodies, and some companies are manufacturing those antibodies as possible treatments. So if you can develop a vaccine, that elicits a very high and long lasting degree of those antibodies, a vaccine may prove useful. Not all the vaccines currently in development are equivalent in developing these antibodies.
White House trade adviser Peter Navarro is leading a Trump administration effort to demand the Food and Drug Administration reverse course and grant a second emergency authorization for the antimalarial drug hydroxychloroquine to treat covid-19, the disease caused by the coronavirus.
Wtf.Does someone in admin have ties to profit off this drug?
Good news, but a long way to go.https://www.cnbc.com/2020/07/14/moderna-says-its-coronavirus-vaccine-trial-produced-robust-immune-response-in-all-patients.html
Good results, but I'm a bit confused. They say this is now the full data, but it seems to contradict some of their preliminary data released, where I don't believe they saw neutralizing antibodies in all groups. They also originally said due to side effects, they were going to cease the high-dose group/studies. But they report more and new results for that group. I'll chalk that up to the prior release being incorrect, and solely to make money for the people that quickly sold options, and this release (which is suggested as peer reviewed), the more accurate one.If so, good news.
https://apnews.com/e4d5259bfc6c74fcb090d885737c55a6?utm_source=Twitter&utm_medium=AP&utm_campaign=SocialFlowUpdate with quotes from Dr. Fauci and a few other doctors.
Good news and less good news regarding the vaccine hunt.https://www.nature.com/articles/s41586-020-2550-z?Infections with the original SARS generates significant immunity 17-years later. Evidence that infection with other coronaviruses may also provide some protection, particularly other beta-coronaviruses. The immunity is driven by T-cells which recognize some of the non-structural proteins that are conserved between the viruses. Less good news. The Moderna vaccine has a poor (or absent) T-cell response. It is suggested that this is by design, as previous SARS vaccines that drive a robust T-cell response have significant side effects. But if the more robust immunity is being driven by the T-cells, then the design strategy of Moderna may not function well, or be particularly durable. Hopefully worst case that means getting a vaccine every year. https://www.nejm.org/doi/full/10.1056/NEJMoa2022483?
Less good news. The Moderna vaccine has a poor (or absent) T-cell response. It is suggested that this is by design, as previous SARS vaccines that drive a robust T-cell response have significant side effects. But if the more robust immunity is being driven by the T-cells, then the design strategy of Moderna may not function well, or be particularly durable. Hopefully worst case that means getting a vaccine every year.
This sounds good. I guess the Lancet will post data Monday. https://news.yahoo.com/hopes-coronavirus-vaccine-boosted-reported-115924064.html
Wow. Widely available in September? Is this far ahead of the Moderna vaccine?
You had expressed concern earlier in this thread (though, could have been a similar thread) about Moderna's release of information very early in the process. There are legitimate reasons sometimes why companies get out in front of news stories.Well you may be proven right. It sure seems like Moderna execs (i.e. insiders by SEC calculations) are doing a lot of selling of shares. That isn't so unusual.... a lot of reasons to sell shares (too big a portion of portfoliio, tax reasons, raise cash for a purchase of a house, etc.). What is suspicious though is very few insiders seem to be buying shares outside of option exercising. And only one reason to buy... knowing you will sell later at a higher price.Perhaps the insiders know the news isn't all going to be good for them down the road?